JG
WST icon

Jefferies Group’s West Pharmaceutical WST Stock Holding History

Jefferies Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2.43M Buy
+9,874
New +$3.01M 0.02% 540
2021
Q3 		– Sell
-8,108
Closed -$2.91M – 2061
2021
Q2 		$2.91M Buy
+8,108
New +$2.68M 0.02% 624
2020
Q2 		– Sell
-2,623
Closed -$399K – 2107
2020
Q1 		$399K Buy
2,623
+423
+19% +$65.1K ﹤0.01% 1401
2019
Q4 		$331K Sell
2,200
-40,618
-95% -$5.91M ﹤0.01% 2031
2019
Q3 		$6.07M Buy
42,818
+26,925
+169% +$3.71M 0.05% 416
2019
Q2 		$1.99M Buy
15,893
+2,255
+17% +$266K 0.01% 929
2019
Q1 		$1.5M Buy
+13,638
New +$1.42M 0.01% 1056
2018
Q4 		– Sell
-3,175
Closed -$392K – 2634
2018
Q3 		$392K Sell
3,175
-8,174
-72% -$917K ﹤0.01% 1732
2018
Q2 		$1.13M Sell
11,349
-6,006
-35% -$553K 0.01% 1191
2018
Q1 		$1.53M Buy
17,355
+4,333
+33% +$405K 0.01% 992
2017
Q4 		$1.28M Buy
+13,022
New +$1.28M 0.01% 1209
2017
Q3 		– Sell
-22,620
Closed -$2.14M – 2653
2017
Q2 		$2.14M Buy
22,620
+10,600
+88% +$975K 0.01% 903
2017
Q1 		$981K Buy
+12,020
New +$1.01M 0.01% 1287
2016
Q3 		– Sell
-8,407
Closed -$638K – 2489
2016
Q2 		$638K Buy
+8,407
New +$612K ﹤0.01% 1322
2016
Q1 		– Sell
-3,316
Closed -$200K – 2611
2015
Q4 		$200K Buy
+3,316
New +$199K ﹤0.01% 1948

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group's WST Position: Q3 2022 in Review

Jefferies Group opened a new position in West Pharmaceutical (WST) in Q3 2022: 9,874 shares worth $2.43M. The stake represents 0.02% of the portfolio and ranks #540 among its holdings. This is a return to the name: Jefferies Group previously reported a position in WST as recently as Q2 2021.

Jefferies Group first reported a position in WST in Q4 2015 and has held it in 15 quarters since. The position peaked at $6.07M in Q3 2019. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Jefferies Group held 9,874 shares of West Pharmaceutical worth $2.43M as of Q3 2022.
  • West Pharmaceutical was a new Jefferies Group position in Q3 2022.
  • West Pharmaceutical made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #540 holding.
  • Jefferies Group first reported a position in West Pharmaceutical in Q4 2015 and has held it in 15 quarters since.
  • Jefferies Group's West Pharmaceutical position peaked at $6.07M in Q3 2019.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.